{
  "hits": 206,
  "size": 6,
  "data": [
    {
      "title": "从药品CRO向医疗器械延伸，BE业务带来业绩增量",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000033",
      "orgName": "长城国瑞证券有限公司",
      "orgSName": "长城国瑞证券",
      "publishDate": "2017-05-15 00:00:00.000",
      "infoCode": "AP201705150581256592",
      "column": "002004001003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.7400000000",
      "predictLastYearPe": "33.6500000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "465",
      "industryName": "医药制造",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 2,
      "reportType": 2,
      "author": [
        "11000229320.黄文忠",
        "11000246940.周豫"
      ],
      "indvIsNew": "001",
      "researcher": "黄文忠,周豫",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 721,
      "attachPages": 17,
      "encodeUrl": "iocQkP+biYZ1leJwJ1n/DfEIpXp1k3pyZQUybtv/MII=",
      "sRatingName": "增持",
      "sRatingCode": "0104",
      "market": "SHENZHEN",
      "authorID": [
        "11000229320",
        "11000246940"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "业绩已开始恢复",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000119",
      "orgName": "群益证券(香港)有限公司",
      "orgSName": "群益证券",
      "publishDate": "2017-04-28 00:00:00.000",
      "infoCode": "AP201704280538831243",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.6800000000",
      "predictLastYearPe": "36.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "465",
      "industryName": "医药制造",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000210658.王睿哲"
      ],
      "indvIsNew": "001",
      "researcher": "王睿哲",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "30.0000000000",
      "indvAimPriceL": "30.0000000000",
      "attachType": "0",
      "attachSize": 234,
      "attachPages": 3,
      "encodeUrl": "OuM6669B/a+8AgbAtVnzlcE3WagMGyA27BaCRAXVwaI=",
      "sRatingName": "买入",
      "sRatingCode": "0104",
      "market": "SHENZHEN",
      "authorID": [
        "11000210658"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "Q1反转获确认，17年高增长确定性增加",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000064",
      "orgName": "华安证券",
      "orgSName": "华安证券",
      "publishDate": "2017-04-27 00:00:00.000",
      "infoCode": "AP201704270536048191",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.6000000000",
      "predictLastYearPe": "41.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "465",
      "industryName": "医药制造",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000250641.医药生物行业组"
      ],
      "indvIsNew": "001",
      "researcher": "医药生物行业组",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 561,
      "attachPages": 4,
      "encodeUrl": "IrCuu8YJWhkMhntKWR+TugzZKx8UcwrNi8otqPJrqXE=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000250641"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "增发获批，一季度业绩明显改善，17年将重返高增长",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000064",
      "orgName": "华安证券股份有限公司",
      "orgSName": "华安证券",
      "publishDate": "2017-04-14 00:00:00.000",
      "infoCode": "AP201704140506532497",
      "column": "002004001003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.6800000000",
      "predictLastYearPe": "37.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "465",
      "industryName": "医药制造",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000250641.医药生物行业组"
      ],
      "indvIsNew": "001",
      "researcher": "医药生物行业组",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 557,
      "attachPages": 3,
      "encodeUrl": "w+2ri6LtJTaIaMlRzZiwr8CSxpYs1tTGcbN1gVAWpBU=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000250641"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "业绩符合预期，17年将恢复高增长",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000064",
      "orgName": "华安证券",
      "orgSName": "华安证券",
      "publishDate": "2017-03-01 00:00:00.000",
      "infoCode": "AP201703010372398526",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.6300000000",
      "predictLastYearPe": "40.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "465",
      "industryName": "医药制造",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000250641.医药生物行业组"
      ],
      "indvIsNew": "001",
      "researcher": "医药生物行业组",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 560,
      "attachPages": 3,
      "encodeUrl": "2/Oz4LeVI71WfUfAND/a5fQriq99ynAbp8hDNDyu8eo=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000250641"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "业绩符合预期，期待17年增速反转",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000064",
      "orgName": "华安证券",
      "orgSName": "华安证券",
      "publishDate": "2017-01-25 00:00:00.000",
      "infoCode": "AP201701250292814970",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.6100000000",
      "predictLastYearPe": "40.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "465",
      "industryName": "医药制造",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": "",
      "indvIsNew": "001",
      "researcher": "",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 568,
      "attachPages": 3,
      "encodeUrl": "+Y8TTTdSrgPb8H0/VdQbNflDp+jsZ5Q1MS49EKCmA3s=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": "",
      "count": 0,
      "orgType": "white"
    }
  ],
  "TotalPage": 5,
  "pageNo": 5,
  "currentYear": 2025
}